1. Home
  2. PAR vs CSTL Comparison

PAR vs CSTL Comparison

Compare PAR & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$14.52

Market Cap

887.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$25.38

Market Cap

806.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
CSTL
Founded
1968
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical Specialities
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.7M
806.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
PAR
CSTL
Price
$14.52
$25.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$36.00
$47.17
AVG Volume (30 Days)
1.4M
397.3K
Earning Date
05-29-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$455,547,000.00
$344,229,000.00
Revenue This Year
$11.10
$2.10
Revenue Next Year
$11.31
$12.63
P/E Ratio
N/A
N/A
Revenue Growth
30.16
3.66
52 Week Low
$15.44
$14.59
52 Week High
$72.15
$44.28

Technical Indicators

Market Signals
Indicator
PAR
CSTL
Relative Strength Index (RSI) 29.00 26.28
Support Level N/A $21.77
Resistance Level $38.44 $34.97
Average True Range (ATR) 1.54 1.38
MACD 0.02 -0.09
Stochastic Oscillator 19.58 7.96

Price Performance

Historical Comparison
PAR
CSTL

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Share on Social Networks: